The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodglick, L.
Right arrow Articles by Braun, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodglick, L.
Right arrow Articles by Braun, J.

The Journal of Immunology, Vol 155, Issue 11 5151-5159, Copyright © 1995 by American Association of Immunologists


ARTICLES

Mapping the Ig superantigen-binding site of HIV-1 gp120

L Goodglick, N Zevit, MS Neshat and J Braun
Department of Pathology and Laboratory Medicine, Jonsson Comprehensive Cancer Center, UCLA School of Medicine 90095, USA.

The envelope glycoprotein, gp120, of HIV-1 has recently been identified as a member of the new family of Ig superantigens (Ig-SAg). This classification is based on the selective binding of gp120 to an unusually high proportion of endogenous, nonimmune Ig, and the selective activation of nonimmune B cells by gp120 in vitro. Many, if not all of the nonimmune Ig that bind to gp120 are members of the VH3 Ig gene family. The aim of this study was to determine the epitope on gp120 that was responsible for its Ig-SAg binding activity. To do this, we utilized a panel of 30 peptides derived from gp160 in a competition- binding assay. For five Igs that were tested, as well as for polyclonal serum IgM, two overlapping peptides (each 20 amino acids in length) were identified that were potent inhibitors of gp120 binding. Similarly, the 10 amino acid overlap region of these two peptides had inhibitory activity. Thus, this decamer sequence represented the optimal Ig-SAg epitope or mimotope. The amino acid residue at position 1 of the decamer, and to a lesser extent at position 10, was critical for peptide binding. In addition to this decamer peptide, other peptides that shared modest sequence homology were also selectively inhibitory for specific Ig samples. These findings provide the first definition of an Ig-SAg ligand at the peptide level and will facilitate further structural and biologic characterization of this new class of pathogenic Ags.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Paul, S. Karle, S. Planque, H. Taguchi, M. Salas, Y. Nishiyama, B. Handy, R. Hunter, A. Edmundson, and C. Hanson
Naturally Occurring Proteolytic Antibodies: SELECTIVE IMMUNOGLOBULIN M-CATALYZED HYDROLYSIS OF HIV gp120
J. Biol. Chem., September 17, 2004; 279(38): 39611 - 39619.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Viau, N. S. Longo, P. E. Lipsky, L. Bjorck, and M. Zouali
Specific In Vivo Deletion of B-Cell Subpopulations Expressing Human Immunoglobulins by the B-Cell Superantigen Protein L
Infect. Immun., June 1, 2004; 72(6): 3515 - 3523.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. W. Scamurra, D. B. Nelson, X. M. Lin, D. J. Miller, G. J. Silverman, T. Kappel, J. R. Thurn, E. Lorenz, A. Kulkarni-Narla, and E. N. Janoff
Mucosal Plasma Cell Repertoire During HIV-1 Infection
J. Immunol., October 1, 2002; 169(7): 4008 - 4016.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. W. Scamurra, D. J. Miller, L. Dahl, M. Abrahamsen, V. Kapur, S. M. Wahl, E. C. B. Milner, and E. N. Janoff
Impact of HIV-1 Infection on VH3 Gene Repertoire of Naive Human B Cells
J. Immunol., May 15, 2000; 164(10): 5482 - 5491.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. N. Neshat, L. Goodglick, K. Lim, and J. Braun
Mapping the B cell superantigen binding site for HIV-1 gp120 on a VH3 Ig
Int. Immunol., March 1, 2000; 12(3): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Patella, G. Florio, A. Petraroli, and G. Marone
HIV-1 gp120 Induces IL-4 and IL-13 Release from Human Fc{epsilon}RI+ Cells Through Interaction with the VH3 Region of IgE
J. Immunol., January 15, 2000; 164(2): 589 - 595.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Karray, L. Juompan, R. C. Maroun, D. Isenberg, G. J. Silverman, and M. Zouali
Structural Basis of the gp120 Superantigen-Binding Site on Human Immunoglobulins
J. Immunol., December 15, 1998; 161(12): 6681 - 6688.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Patella, A. Giuliano, J.-P. Bouvet, and G. Marone
Endogenous Superallergen Protein Fv Induces IL-4 Secretion from Human Fc{epsilon}RI+ Cells Through Interaction with the VH3 Region of IgE
J. Immunol., November 15, 1998; 161(10): 5647 - 5655.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. Juompan, P. Lambin, and M. Zouali
Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection
FASEB J, November 1, 1998; 12(14): 1473 - 1480.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Karray and M. Zouali
Identification of the B cell superantigen-binding site of HIV-1 gp120
PNAS, February 18, 1997; 94(4): 1356 - 1360.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.